S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

NASDAQ:SCPH - Scpharmaceuticals Stock Price, Forecast & News

$7.13
-0.27 (-3.65 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$7.00
Now: $7.13
$7.40
50-Day Range
$5.81
MA: $8.22
$10.45
52-Week Range
$2.44
Now: $7.13
$10.95
Volume13,252 shs
Average Volume83,041 shs
Market Capitalization$149.60 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.17
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outside of the acute care setting. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.
Read More
Scpharmaceuticals logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SCPH
CUSIPN/A
Phone617-517-0730

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.76 per share

Profitability

Net Income$-33,000,000.00

Miscellaneous

Employees21
Market Cap$149.60 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive SCPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.


Scpharmaceuticals (NASDAQ:SCPH) Frequently Asked Questions

How has Scpharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Scpharmaceuticals' stock was trading at $7.77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SCPH stock has decreased by 8.2% and is now trading at $7.13. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Scpharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scpharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Scpharmaceuticals.

When is Scpharmaceuticals' next earnings date?

Scpharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Scpharmaceuticals.

How were Scpharmaceuticals' earnings last quarter?

Scpharmaceuticals Inc (NASDAQ:SCPH) posted its earnings results on Tuesday, March, 24th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.52) by $0.06. View Scpharmaceuticals' earnings history.

What price target have analysts set for SCPH?

1 brokerages have issued 1-year target prices for Scpharmaceuticals' shares. Their forecasts range from $13.00 to $13.00. On average, they expect Scpharmaceuticals' share price to reach $13.00 in the next year. This suggests a possible upside of 82.3% from the stock's current price. View analysts' price targets for Scpharmaceuticals.

Has Scpharmaceuticals been receiving favorable news coverage?

News headlines about SCPH stock have been trending neutral on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Scpharmaceuticals earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutScpharmaceuticals.

Are investors shorting Scpharmaceuticals?

Scpharmaceuticals saw a increase in short interest in March. As of March 13th, there was short interest totaling 6,500 shares, an increase of 58.5% from the February 27th total of 4,100 shares. Based on an average trading volume of 78,300 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the company's shares are sold short. View Scpharmaceuticals' Current Options Chain.

Who are some of Scpharmaceuticals' key competitors?

What other stocks do shareholders of Scpharmaceuticals own?

Who are Scpharmaceuticals' key executives?

Scpharmaceuticals' management team includes the following people:
  • Mr. John H. Tucker, Pres, CEO, CFO & Director (Age 56)
  • Dr. Pieter Muntendam, Consultant (Age 61)
  • Ms. Rachael Nokes, Principal Accounting Officer
  • Katherine Taudvin, Director of Corp. Devel. & Investor Relations
  • Dr. John Mohr Pharm.D., Sr. VP of Clinical Devel. & Medical Affairs

When did Scpharmaceuticals IPO?

(SCPH) raised $96 million in an IPO on Friday, November 17th 2017. The company issued 6,400,000 shares at $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

What is Scpharmaceuticals' stock symbol?

Scpharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

How do I buy shares of Scpharmaceuticals?

Shares of SCPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Scpharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $7.13.

How big of a company is Scpharmaceuticals?

Scpharmaceuticals has a market capitalization of $149.60 million. The company earns $-33,000,000.00 in net income (profit) each year or ($1.77) on an earnings per share basis. Scpharmaceuticals employs 21 workers across the globe. View additional information about Scpharmaceuticals.

What is Scpharmaceuticals' official website?

The official website for Scpharmaceuticals is http://www.scpharma.com/.

How can I contact Scpharmaceuticals?

Scpharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The company can be reached via phone at 617-517-0730 or via email at [email protected]


MarketBeat Community Rating for Scpharmaceuticals (NASDAQ SCPH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  276
MarketBeat's community ratings are surveys of what our community members think about Scpharmaceuticals and other stocks. Vote "Outperform" if you believe SCPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel